Table 2 Procedure related characteristics between the tranexamic acid and control groups
Characteristic | All patients (n = 135) | Tranexamic acid (n = 52) | Control (n = 83) | P-value |
|---|---|---|---|---|
INR at the day of implanta | 2.1 (1.9–2.5) | 2.1(1.9–2.5) | 2.1(1.9–2.5) | 0.932 |
Generator exchange and/or pocket revision, n (%) | 14 (10.4) | 5 (9.6) | 9 (10.8) | 0.968 |
New implantation, n (%) | 101 (74.8) | 39 (75.0) | 62 (74.7) | 1.0 |
Upgrade and/or lead revision, n (%) | 20 (14.8) | 8 (15.4) | 12 (14.5) | 1.0 |
Pacemaker, n (%) | 24 (17.8) | 9 (17.3) | 15 (18.1) | 1.0 |
ICD, n (%) | 111 (83) | 43 (82.7) | 68 (81.9) | |
Number of leads implanted | ||||
One, n (%) | 26 (19.3) | 12 (23.1) | 14 (16.9) | 0.505 |
Two, n (%) | 50 (37.0) | 18 (34.6) | 32 (38.6) | 0.645 |
Three, n (%) | 45 (33.3) | 17 (32.7) | 28 (33.7) | 0.900 |
Submuscular pocket, n (%) | 5 (3.7) | 2 (3.8) | 3 (3.6) | 1.0 |
Venous route other than subclavian | ||||
Axillary, n (%) | 12 (8.9) | 4 (7.7) | 8 (9.6) | 0.767 |
Cephalic, n (%) | 7 (5.2) | 3 (5.8) | 4 (4.8) | 1.0 |